Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Exchange Rate Effect (2021 - 2026)

Valneva SE (VALN) posted Exchange Rate Effect of $400395.0 for Q1 2026, up 6.82% sequentially from $374822.0 in Q4 2025, and up 164.52% YoY from $151368.8 in Q1 2025.

Analysis

Valneva SE (VALN) Exchange Rate Effect (2021 - 2026) Analysis & Trends

Valneva SE has reported Exchange Rate Effect for 6 years, with the latest figure at $400395.0 in Q1 2026.

  • Quarterly Exchange Rate Effect rose 164.52% year-over-year to $400395.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 276.12% YoY) and the FY2025 annual result came in at -$4.0 million, down 301.74% from the prior year.
  • Exchange Rate Effect grew to $400395.0 in Q1 2026 per VALN's latest filing, from $374822.0 in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $633.2 million in Q3 2023 and troughed at -$633.4 million in Q2 2023.
  • A 5-year average of -$160233.8 and a median of -$49100.3 in 2025 frame the typical range for Exchange Rate Effect.
  • The widest YoY moves for Exchange Rate Effect: up 58979.99% in 2023, down 69281.37% in 2023.
  • Over 5 years, Exchange Rate Effect stood at -$2.7 million in 2022, then surged by 104.43% to $119429.3 in 2023, then surged by 1969.56% to $2.5 million in 2024, then plunged by 84.84% to $374822.0 in 2025, then gained by 6.82% to $400395.0 in 2026.
  • According to Business Quant data, Exchange Rate Effect over the past three periods registered $400395.0, $374822.0, and -$49100.3 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -3.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -300,000.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -2.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 19.84 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.45 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -287,000.00
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn 180,166.09
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 180,166.09
Mar 31, 2026 400,395.01
Dec 31, 2025 374,822.01
Sep 30, 2025 -49,100.31
Jun 30, 2025 -3.49 Mn
Mar 31, 2025 -620,611.82
Dec 31, 2024 2.47 Mn
Sep 30, 2024 -1.18 Mn
Jun 30, 2024 903,508.68
Mar 31, 2024 -286,799.51
Dec 31, 2023 119,429.33
Sep 30, 2023 633.22 Mn
Jun 30, 2023 -633.38 Mn
Mar 31, 2023 -369,229.59
Dec 31, 2022 -2.70 Mn
Sep 30, 2022 1.07 Mn
Jun 30, 2022 915,534.64
Mar 31, 2022 -120,090.14
Dec 31, 2021 1.87 Mn
Sep 30, 2021 96,701.56